Dr. Michael David Mirmanesh , MD
Plastic Surgery • Pinellas Park, FL
6650 78th Ave N
Pinellas Park, FL 337812053
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Michael Mirmanesh is listed in NPPES under Plastic Surgery.
-
NPI assigned on May 16, 2014; this date does not establish years in practice.
-
Published CMS data list 514 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Levothyroxine Sodium — 63 prescription fills, including refills.
- Atorvastatin Calcium — 42 prescription fills, including refills.
- Rosuvastatin Calcium — 34 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 23 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Part D prescriptions than 95% of clinicians listed under Plastic Surgery in Florida (2024, 213 clinicians with data). Median for this group: 69. Middle half: 28 to 161.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 103 in 2020 to 514 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020–2024.
Practice Location & Contact Primary Location
6650 78th Ave N
Pinellas Park, FL 337812053
What Public CMS Data Show
Plastic Surgery: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
1,164 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$14,715 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $44,284.15 across 10 records.
By nature of payment
- Food and Beverage: $44,284.15 across 10 records.
Reporting-company totals (3 largest of 6)
- Lumenis BE inc: $43,713.94 across 1 record.
- MERZ NORTH AMERICA, INC.: $182.09 across 2 records.
- Medtronic, Inc.: $165.36 across 2 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2014
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Compared with the same specialty in Pinellas Park and Florida
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
More Part D prescriptions than 95% of clinicians listed under Plastic Surgery in Florida (2024, 213 clinicians with data). Median for this group: 69. Middle half: 28 to 161.
Too few clinicians listed under Plastic Surgery in Pinellas Park have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Plastic Surgery in Florida (2024, 213 clinicians with data). Median for this group: $417. Middle half: $158 to $1,026.
Too few clinicians listed under Plastic Surgery in Pinellas Park have Medicare Part D data for 2024 to compare.
2 active clinicians are listed under Plastic Surgery with a practice address in Pinellas Park, FL (507 in Florida).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 399% from 103 in 2020 to 514 in 2024.
- 2020: 103
- 2021: 217
- 2022: 413
- 2023: 455
- 2024: 514
-
30-day fills
30-day fills increased 436% from 217 in 2020 to 1,164 in 2024.
- 2020: 217
- 2021: 484
- 2022: 859
- 2023: 1,015
- 2024: 1,164
-
Part D drug cost
Part D drug cost increased 105% from $7,183 in 2020 to $14,715 in 2024.
- 2020: $7,183
- 2021: $14,892
- 2022: $18,239
- 2023: $5,614
- 2024: $14,715
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 148% from $17,885.75 in 2021 to $44,284.15 in 2025.
- 2021: $17,885.75
- 2022: $65,023.21
- 2023: $31,960.68
- 2024: $17,876.10
- 2025: $44,284.15
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): fewer than 11 records totaling $44,284.15.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Lumenis BE inc |
Food and Beverage
Cash or cash equivalent
|
M22 | General | $43,713.94 |
| MERZ NORTH AMERICA, INC. |
Food and Beverage
In-kind items and services
|
Xeomin | General | $148.50 |
| Medtronic, Inc. |
Food and Beverage
In-kind items and services
|
INCEPTIV | General | $140.79 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $125.00 |
| Mentor Worldwide LLC |
Food and Beverage
In-kind items and services
|
MENTOR MemoryGel Resterilizable Gel Sizer | General | $36.61 |
| MERZ NORTH AMERICA, INC. |
Food and Beverage
In-kind items and services
|
Xeomin | General | $33.59 |
| Medtronic, Inc. |
Food and Beverage
In-kind items and services
|
VANTA ADAPTIVESTIM | General | $24.57 |
| REVANCE THERAPEUTICS, INC. |
Food and Beverage
In-kind items and services
|
DAXXIFY | General | $22.29 |
| REVANCE THERAPEUTICS, INC. |
Food and Beverage
In-kind items and services
|
DAXXIFY | General | $19.57 |
| REVANCE THERAPEUTICS, INC. |
Food and Beverage
In-kind items and services
|
DAXXIFY | General | $19.29 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 63 | 5,174 | $647.25 | 23 |
| Atorvastatin Calcium | Atorvastatin Calcium | 42 | 3,300 | $367.52 | 14 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 34 | 2,970 | $432.48 | 11 |
| Azithromycin | Azithromycin | 31 | 155 | $150.85 | 28 |
| Methylprednisolone | Methylprednisolone | 29 | 174 | $193.03 | 26 |
| Losartan Potassium | Losartan Potassium | 25 | 2,035 | $313.59 | — |
| Amlodipine Besylate | Amlodipine Besylate | 24 | 1,845 | $119.32 | — |
| Montelukast Sodium | Montelukast Sodium | 24 | 1,260 | $351.20 | — |
| Allopurinol | Allopurinol | 21 | 1,374 | $258.38 | — |
| Omeprazole | Omeprazole | 21 | 1,535 | $190.24 | — |
| Metoprolol Succinate | Metoprolol Succinate | 20 | 1,800 | $469.38 | — |
| Metoprolol Tartrate | Metoprolol Tartrate | 19 | 1,636 | $174.90 | — |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 19 | 143 | $275.86 | 18 |
| Escitalopram Oxalate | Escitalopram Oxalate | 18 | 1,620 | $466.89 | — |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 18 | 1,620 | $192.35 | — |
| Metformin Hcl | Metformin Hcl | 15 | 1,230 | $289.63 | — |
| Sumatriptan Succinate | Sumatriptan Succinate | 15 | 450 | $101.44 | — |
| Carvedilol | Carvedilol | 14 | 1,260 | $110.36 | — |
| Gabapentin | Gabapentin | 13 | 500 | $334.74 | — |
| Pantoprazole Sodium | Pantoprazole Sodium | 13 | 1,050 | $279.76 | — |
| Eliquis | Apixaban | 13 | 390 | $8,589.79 | — |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 12 | 291 | $250.15 | — |
| Tamsulosin Hcl | Tamsulosin Hcl | 11 | 990 | $155.70 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2025-05-30NUCC Taxonomy Code: 208200000X
A plastic surgeon deals with the repair, reconstruction or replacement of physical defects of form or function involving the skin, musculoskeletal system, craniomaxillofacial structures, hand, extremities, breast and trunk and external genitalia or cosmetic enhancement of these areas of the body. Cosmetic surgery is an essential component of plastic surgery. The plastic surgeon uses cosmetic surgical principles to both improve overall appearance and to optimize the outcome of reconstructive procedures. The surgeon uses aesthetic surgical principles not only to improve undesirable qualities of normal structures but in all reconstructive procedures as well.
NUCC Taxonomy Code: 208200000X
A plastic surgeon deals with the repair, reconstruction or replacement of physical defects of form or function involving the skin, musculoskeletal system, craniomaxillofacial structures, hand, extremities, breast and trunk and external genitalia or cosmetic enhancement of these areas of the body. Cosmetic surgery is an essential component of plastic surgery. The plastic surgeon uses cosmetic surgical principles to both improve overall appearance and to optimize the outcome of reconstructive procedures. The surgeon uses aesthetic surgical principles not only to improve undesirable qualities of normal structures but in all reconstructive procedures as well.
NUCC Taxonomy Code: 208200000X
A plastic surgeon deals with the repair, reconstruction or replacement of physical defects of form or function involving the skin, musculoskeletal system, craniomaxillofacial structures, hand, extremities, breast and trunk and external genitalia or cosmetic enhancement of these areas of the body. Cosmetic surgery is an essential component of plastic surgery. The plastic surgeon uses cosmetic surgical principles to both improve overall appearance and to optimize the outcome of reconstructive procedures. The surgeon uses aesthetic surgical principles not only to improve undesirable qualities of normal structures but in all reconstructive procedures as well.
NUCC Taxonomy Code: 208200000X
A plastic surgeon deals with the repair, reconstruction or replacement of physical defects of form or function involving the skin, musculoskeletal system, craniomaxillofacial structures, hand, extremities, breast and trunk and external genitalia or cosmetic enhancement of these areas of the body. Cosmetic surgery is an essential component of plastic surgery. The plastic surgeon uses cosmetic surgical principles to both improve overall appearance and to optimize the outcome of reconstructive procedures. The surgeon uses aesthetic surgical principles not only to improve undesirable qualities of normal structures but in all reconstructive procedures as well.
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 6650 78TH AVE N, PINELLAS PARK, FL 337812053 (Tel: 7276105335)
Registered at 6650 78TH AVE N, PINELLAS PARK, FL 337812053 (Tel: 7276105335)
Plastic Surgery (license number reported to NPPES: NJ 25MA10070800)
Registered at 100 ROUTE 73, VOORHEES, NJ 080439575 (Tel: 8562821338)
Plastic Surgery (license number reported to NPPES: DE C1-0013021)
Registered at 100 ROUTE 73, VOORHEES, NJ 080439575 (Tel: 8562821338)
NPI status registered as active in NPPES database
Registered at 2221 STOCKTON BLVD, ROOM 2125, SACRAMENTO, CA 958171418 (Tel: 9167342011)
Registered at 2221 STOCKTON BLVD, ROOM 2125, SACRAMENTO, CA 958171418 (Tel: 9167342011)
Recorded as MICHAEL MIRMANESH, M.D.
Plastic Surgery (license number reported to NPPES: CA 141171)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Mailing Address
6650 78th Ave N
Pinellas Park, FL 337812053
Phone: 7276105335